SARDU, Celestino
 Distribuzione geografica
Continente #
EU - Europa 10.563
NA - Nord America 5.790
AS - Asia 5.066
SA - Sud America 737
Continente sconosciuto - Info sul continente non disponibili 396
AF - Africa 87
OC - Oceania 8
Totale 22.647
Nazione #
RU - Federazione Russa 6.617
US - Stati Uniti d'America 5.571
IT - Italia 1.817
SG - Singapore 1.561
CN - Cina 906
VN - Vietnam 882
IE - Irlanda 876
HK - Hong Kong 798
BR - Brasile 606
GB - Regno Unito 301
IN - India 284
DE - Germania 282
KR - Corea 251
FR - Francia 133
UA - Ucraina 120
JP - Giappone 100
CA - Canada 97
TR - Turchia 71
FI - Finlandia 66
NL - Olanda 59
GR - Grecia 54
SE - Svezia 45
MX - Messico 40
BD - Bangladesh 39
AR - Argentina 38
AT - Austria 35
EC - Ecuador 25
DK - Danimarca 22
PL - Polonia 22
CZ - Repubblica Ceca 21
ZA - Sudafrica 21
PK - Pakistan 20
ID - Indonesia 19
IQ - Iraq 19
CO - Colombia 18
BE - Belgio 17
IR - Iran 14
LT - Lituania 14
CR - Costa Rica 13
ET - Etiopia 13
PY - Paraguay 13
CL - Cile 11
EG - Egitto 11
SC - Seychelles 11
ES - Italia 10
GT - Guatemala 10
IL - Israele 10
JM - Giamaica 10
SA - Arabia Saudita 10
TT - Trinidad e Tobago 10
VE - Venezuela 10
EE - Estonia 9
MA - Marocco 9
PE - Perù 9
AU - Australia 8
KE - Kenya 8
UZ - Uzbekistan 8
MY - Malesia 7
PT - Portogallo 7
RO - Romania 7
SV - El Salvador 7
TW - Taiwan 7
AZ - Azerbaigian 6
CH - Svizzera 6
HN - Honduras 6
JO - Giordania 6
NI - Nicaragua 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
TN - Tunisia 5
BB - Barbados 4
OM - Oman 4
RS - Serbia 4
TH - Thailandia 4
UY - Uruguay 4
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
CY - Cipro 3
DZ - Algeria 3
GE - Georgia 3
HU - Ungheria 3
LV - Lettonia 3
NP - Nepal 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
AL - Albania 2
AM - Armenia 2
BM - Bermuda 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
MM - Myanmar 2
PA - Panama 2
SI - Slovenia 2
SN - Senegal 2
AN - Antille olandesi 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BZ - Belize 1
Totale 22.232
Città #
Moscow 2.409
San Jose 930
Dublin 867
Hong Kong 762
Singapore 701
Santa Clara 544
Ashburn 522
Naples 413
Council Bluffs 367
Chandler 304
Ho Chi Minh City 288
Seoul 248
Jacksonville 218
Hanoi 216
Bengaluru 190
Hefei 190
Dallas 165
Caserta 158
The Dalles 154
Milan 149
Beijing 143
New York 114
Princeton 111
Los Angeles 96
Roxbury 95
Munich 83
Ann Arbor 75
Medford 70
São Paulo 63
Bremen 58
Da Nang 57
Aversa 50
Wilmington 48
Rome 42
Haiphong 38
Cambridge 37
Amsterdam 35
Woodbridge 34
Istanbul 31
Ercolano 30
Falkenstein 30
North Bergen 30
Chicago 29
Salerno 28
Napoli 27
Orem 27
Des Moines 25
Kochi 25
Atlanta 24
Memphis 22
Nuremberg 22
Phoenix 22
Biên Hòa 21
Montreal 21
Miano 20
Toronto 20
Brno 19
Juelsminde 19
Boardman 18
Frankfurt am Main 18
Nanjing 18
Turku 18
Bari 17
Brooklyn 17
Houston 17
Boydton 16
Brussels 16
London 16
Mexico City 16
Tokyo 16
Vienna 16
Warsaw 16
Giugliano In Campania 15
Helsinki 15
Hải Dương 15
Denver 14
Sarno 14
Addis Ababa 13
Chennai 13
Mountain View 13
Rio de Janeiro 13
Shanghai 13
Brasília 12
Redwood City 12
San Francisco 12
San Mateo 12
Düsseldorf 11
Hillsboro 11
Johannesburg 11
Lappeenranta 11
Ninh Bình 11
San José 11
Tianjin 11
Bologna 10
Boston 10
Manchester 10
Paris 10
Porto Alegre 10
Seattle 10
Vicenza 10
Totale 12.104
Nome #
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events 357
Abdominal fat SIRT6 expression and its relationship with inflammatory and metabolic pathways in pre-diabetic overweight patients 258
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 229
Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes. 213
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 210
Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment 205
Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders 204
123I-MIBG Scintigraphy in the Subacute State of Takotsubo Cardiomyopathy. 203
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 196
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 195
Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: Effects of metformin 194
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 194
Cardiac syncope recurrence in type 2 diabetes mellitus patients vs. normoglycemics patients: The CARVAS study 185
Awaking blood pressure surge and progression to microalbuminuria in type 2 normotensive diabetic patients 184
MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients 184
Inflammatory cytokines and SIRT1 levels in subcutaneous abdominal fat: Relationship with cardiac performance in overweight pre-diabetics patients 180
Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvage 178
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 177
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts 173
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 172
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside 171
Molecular mechanisms and therapeutic targets of inflammatory-related Cardiovascular diseases: from molecular mechanisms to therapeutic targets 171
Atherosclerotic plaque fissuration and clinical outcomes in pre-diabetics vs. normoglycemics patients affected by asymptomatic significant carotid artery stenosis at 2 years of follow-up: Role of micrornas modulation: The atimir study 170
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 168
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 168
Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients 167
MRI in Pregnancy and Precision Medicine: A Review from Literature 165
Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism? 165
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts 164
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 163
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte 163
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 163
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 162
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients? 161
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 161
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes 159
Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis 157
Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest 156
SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells 155
[HIV and related infections in Italian penal institutions: epidemiological and health organization note] 155
Metformin therapy effects on the expression of sodium-glucose cotransporter 2, leptin, and sirt6 levels in pericoronary fat excised from pre-diabetic patients with acute myocardial infarction 155
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 154
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 154
Pre-Menopausal Breast Fat Density Might Predict MACE During 10 Years of Follow-Up: The BRECARD Study 153
Hyperglycaemia on admission to hospital and COVID-19 151
Metabolic syndrome is associated with a poor outcome in patients affected by outflow tract premature ventricular contractions treated by catheter ablation. 150
DNA methylation profiling of CD04+/CD08+ T cells reveals pathogenic mechanisms in increasing hyperglycemia: PIRAMIDE pilot study 150
Use of a non-specific immunomodulation therapy as a therapeutic vasculogenesis strategy in no-option critical limb ischemia patients 149
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells 149
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 146
Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism. 146
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry 146
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 145
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study 145
Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19 145
The dating of thrombus organization in cases of pulmonary embolism: An autopsy study 145
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes 145
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 145
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 144
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment 144
Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: Effects of incretin treatment 143
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 143
Cardiovascular benefits from gliflozins: Effects on endothelial function 142
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 141
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 140
Automated 3D Ultrasound as an Adjunct to Screening Mammography Programs in Dense Breast: Literature Review and Metanalysis 140
Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up 140
Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome 139
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque 138
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 137
Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillator 136
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 135
Dietary Epigenetic Modulators: Unravelling the Still-Controversial Benefits of miRNAs in Nutrition and Disease 135
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes 134
Advances in Nanomedicine for Precision Insulin Delivery 133
Effects of Alpha Lipoic Acid on Multiple Cytokines and Biomarkers and Recurrence of Atrial Fibrillation Within 1 Year of Catheter Ablation. 132
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry 131
Cardiac biomarkers predict 1-year mortality in elderly patients undergoing hip fracture surgery 131
Effects of α-lipoic acid therapy on sympathetic heart innervation in patients with previous experience of transient takotsubo cardiomyopathy 130
Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes. 130
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 130
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 130
Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes 128
Glycation of ryanodine receptor in circulating lymphocytes predicts the response to cardiac resynchronization therapy 128
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 127
Author's reply 126
Functional role of miRNA in cardiac resynchronization therapy. 125
Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes 125
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 125
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 123
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: Clinical outcomes at 1-year follow-up 123
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up (vol 17, pg 512, 2018) 123
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 122
Comparative Outcomes After Percutaneous Coronary Intervention in Unconscious and Conscious Patients With Out-of-Hospital Cardiac Arrest. 121
Effects of metformin therapy on COronary endothelial DYsfunction in prediabetic patients With stable angina and Non Obstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study. 121
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 120
Calcium release channel RyR2 regulates insulin release and glucose homeostasis 120
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry 120
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction 120
SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study 118
Totale 15.521
Categoria #
all - tutte 78.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.683


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022765 0 0 0 26 208 14 41 34 44 71 82 245
2022/20231.489 125 53 41 64 182 84 23 70 768 24 25 30
2023/2024921 58 58 40 50 243 106 20 18 17 49 89 173
2024/20253.003 40 50 30 103 381 349 445 294 368 460 242 241
2025/202612.615 569 784 677 556 929 6.201 1.011 647 457 392 228 164
2026/20272.327 140 317 801 1.069 0 0 0 0 0 0 0 0
Totale 22.647